Science Explorer Back to mapMap

Most cited papers from Helsana Group (Switzerland)

What are the most cited papers from Helsana Group (Switzerland)?

The most cited paper from Helsana Group (Switzerland) is "Multimorbidity, health care utilization and costs in an elderly community-dwelling population: a claims data based observational study" (Caroline Bähler, Carola A. Huber, Beat Brüngger et al., 2015), with 511 citations. Next come "Identifying patients with chronic conditions using pharmacy data in Switzerland: an updated mapping approach to the classification of medications" (217) and "Potentially Inappropriate Medication Use in Older Patients in Swiss Managed Care Plans: Prevalence, Determinants and Association with Hospitalization" (146).

Showing 50 of 60 papers. Every paper with more than 18 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Multimorbidity, health care utilization and costs in an elderly community-dwelling population: a claims data based observational study Caroline Bähler, Carola A. Huber, Beat Brüngger et al. · BMC Health Services Research Open access 21 Jan 2015 511
2 Identifying patients with chronic conditions using pharmacy data in Switzerland: an updated mapping approach to the classification of medications Carola A. Huber, Thomas D. Szucs, Roland Rapold et al. · BMC Public Health Open access 30 Oct 2013 217
3 Potentially Inappropriate Medication Use in Older Patients in Swiss Managed Care Plans: Prevalence, Determinants and Association with Hospitalization Oliver M. Reich, Thomas Johannes Rosemann, Roland Rapold et al. · PLoS ONE Open access 19 Aug 2014 146
4 Impact of warmer climate periods on flood hazard in the European Alps Bruno Wilhelm, William Rapuc, Benjamin Amann et al. · Nature Geoscience Open access 27 Jan 2022 103
5 Consensus recommendations on how to assess the quality of surgical interventions Anja Domenghino et al. · Nature Medicine Open access Apr 2023 98
6 Polypharmacy and Potentially Inappropriate Medication in the Adult, Community-Dwelling Population in Switzerland Eva Blozik, Roland Rapold, Jan von Overbeck et al. · Drugs & Aging 3 Apr 2013 88
7 Chronic comorbidities associated with inflammatory bowel disease: prevalence and impact on healthcare costs in Switzerland Caroline Bähler, Alain M. Schoepfer, Stephan R. Vavricka et al. · European Journal of Gastroenterology & Hepatology 3 May 2017 84
8 Epidemiology and costs of diabetes mellitus in Switzerland: an analysis of health care claims data, 2006 and 2011 Carola A. Huber, Matthias M. Schwenkglenks, Roland Rapold et al. · BMC Endocrine Disorders Open access 3 Jun 2014 66
9 An empirical investigation of the efficiency effects of integrated care models in Switzerland Oliver M. Reich, Roland Rapold, Magdalena Thöni · International Journal of Integrated Care Open access 13 Jan 2012 64
10 Place of death and health care utilization for people in the last 6 months of life in Switzerland: a retrospective analysis using administrative data Oliver M. Reich, Andri Signorell, André R. Busato · BMC Health Services Research Open access 25 Mar 2013 62
11 Post-myocardial Infarction (MI) Care: Medication Adherence for Secondary Prevention After MI in a Large Real-world Population Carola A. Huber, Matthias R. Meyer, Jan Steffel et al. · Clinical Therapeutics 24 Dec 2018 61
12 Potentially inappropriate proton-pump inhibitor prescription in the general population: a claims-based retrospective time trend analysis Leander Muheim, Andri Signorell, Stefan Markun et al. · Therapeutic Advances in Gastroenterology Open access 2021 59
13 How much does the treatment of each major disease cost? A decomposition of Swiss National Health Accounts Simon Wieser, Marco Riguzzi, Mark Pletscher et al. · The European Journal of Health Economics Open access 22 Feb 2018 59
14 The Evolution of Health Care Utilisation and Costs for Inflammatory Bowel Disease Over Ten Years Nadia Pillai et al. · Journal of Crohn s and Colitis 169 authors 14 Jan 2019 58
15 Improved prediction of medical expenditures and health care utilization using an updated chronic disease score and claims data Carola A. Huber, Sebastian Schneeweiß, Andri Signorell et al. · Journal of Clinical Epidemiology 9 Jul 2013 58
16 Changes over time in prescription practices of pain medications in Switzerland between 2006 and 2013: an analysis of insurance claims Maria Monika Wertli, Oliver M. Reich, Andri Signorell et al. · BMC Health Services Research Open access 27 Feb 2017 56
17 The Swiss Cohort Study on Substance Use Risk Factors – Findings of two Waves Gerhard E. Gmel et al. · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice Open access Aug 2015 55
18 Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014 Caroline Bähler, Stephan R. Vavricka, Alain M. Schoepfer et al. · BMC Gastroenterology Open access Dec 2017 53
19 Antibiotic use in adult outpatients in Switzerland in relation to regions, seasonality and point of care tests Rita Achermann, Katja Suter, Andreas Kronenberg et al. · Clinical Microbiology and Infection Open access Oct 2010 53
20 Benzodiazepine Use and Risk of Developing Alzheimer’s Disease: A Case-Control Study Based on Swiss Claims Data Fabienne Anne-Marie Biétry, Alena M. Pfeil, Oliver M. Reich et al. · CNS Drugs 11 Jan 2017 52
21 Regional Variation of Cost of Care in the Last 12 Months of Life in Switzerland Radoslaw Panczak, Xhyljeta Luta, Maud Maessen et al. · Medical Care Open access 30 Aug 2016 52
22 The gap between scientific evidence and clinical practice: 5‐aminosalicylates are frequently used for the treatment of Crohn's disease Alain M. Schoepfer, M. Bortolotti, Valerie E. H. Pittet et al. · Alimentary Pharmacology & Therapeutics 22 Aug 2014 50
23 The relationship between functional health literacy and the use of the health system by diabetics in Switzerland Johan Franzén, Sarah Mantwill, Roland Rapold et al. · European Journal of Public Health Open access 23 Dec 2013 49
24 On the radiative pion decay Rene Unterdorfer, H. Pichl · The European Physical Journal C Open access 18 Apr 2008 49
25 One-year adherence to oral antihyperglycemic medication and risk prediction of patient outcomes for adults with diabetes mellitus Carola A. Huber, Roland Rapold, Beat Brüngger et al. · Medicine Open access Jun 2016 44
26 Medication adherence in patients with diabetes mellitus: does physician drug dispensing enhance quality of care? Evidence from a large health claims database in Switzerland Carola A. Huber, Oliver M. Reich · Patient Preference and Adherence Open access Sep 2016 43
27 Effect of Antibiotic Prescription Audit and Feedback on Antibiotic Prescribing in Primary Care Soheila Aghlmandi, Florian Samuel Halbeisen, Ramon T. Saccilotto et al. · JAMA Internal Medicine Open access 6 Feb 2023 42
28 Cost-Effectiveness Analysis of Sofosbuvir Compared to Current Standard Treatment in Swiss Patients with Chronic Hepatitis C Alena M. Pfeil, Oliver M. Reich, I. Guerra et al. · PLoS ONE Open access 14 May 2015 41
29 Factors associated with health-related quality of life among home-dwelling older adults aged 75 or older in Switzerland: a cross-sectional study Flaka Siqeca, Olivia Yip, María José Mendieta et al. · Health and Quality of Life Outcomes Open access 21 Dec 2022 38
30 Antidepressant prescription practice and related factors in Switzerland: a cross-sectional analysis of health claims data Elisa Haller, Birgit Watzke, Eva Blozik et al. · BMC Psychiatry Open access 24 Jun 2019 36
31 Benzodiazepine and Z-Drug Use in Switzerland: Prevalence, Prescription Patterns and Association with Adverse Healthcare Outcomes Salome Landolt, Thomas Johannes Rosemann, Eva Blozik et al. · Neuropsychiatric Disease and Treatment Open access Apr 2021 35
32 Drug prescription patterns, polypharmacy and potentially inappropriate medication in Swiss nursing homes: a descriptive analysis based on claims data Rahel Schneider, Daphne Reinau, Nadine Schur et al. · Swiss Medical Weekly Open access 30 Sep 2019 34
33 How does hospitalization affect continuity of drug therapy: an exploratory study Eva Blozik, Andri Signorell, Oliver M. Reich · Therapeutics and Clinical Risk Management Open access Aug 2016 34
34 Estimating the prevalence of comorbid conditions and their effect on health care costs in patients with diabetes mellitus in Switzerland Carola A. Huber, Peter Diem, Matthias M. Schwenkglenks et al. · Diabetes Metabolic Syndrome and Obesity Open access Oct 2014 32
35 CDS Spreads and Contagion Amongst Systemically Important Financial Institutions – A Spatial Econometric Approach Armin Eder, Sebastian Keiler · International Journal of Finance & Economics 16 Aug 2015 30
36 Prediction of health care expenditure increase: how does pharmacotherapy contribute? Annika M. Jödicke, Urs Zellweger, Ivan T. Tomka et al. · BMC Health Services Research Open access Dec 2019 29
37 Health Care Utilisation and Transitions between Health Care Settings in the Last 6 Months of Life in Switzerland Caroline Bähler, Andri Signorell, Oliver M. Reich · PLoS ONE Open access 6 Sep 2016 28
38 Applying Salutogenesis in the Workplace Gregor J. Jenny, Georg Friedrich Bauer, Hege Forbech Vinje et al. Book chapterOpen access 2022 27
39 Variation of colorectal, breast and prostate cancer screening activity in Switzerland: Influence of insurance, policy and guidelines Agnė Ulytė, Wenjia Wei, Holger Dressel et al. · PLoS ONE Open access 16 Apr 2020 27
40 Effects of Integrated Care on Disease-Related Hospitalisation and Healthcare Costs in Patients with Diabetes, Cardiovascular Diseases and Respiratory Illnesses: A Propensity-Matched Cohort Study in Switzerland Thomas Rosemann · International Journal of Integrated Care Open access 8 Apr 2016 27
41 Perinatal mental disorders in Switzerland: prevalence estimates and use of mental-health services Anke Berger, Nicole Bachmann, Andri Signorell et al. · Swiss Medical Weekly Open access 7 Mar 2017 25
42 Comparison of Outcomes and Costs of Ranibizumab and Aflibercept Treatment in Real-Life Martin Schmid, Oliver M. Reich, Livia Faes et al. · PLoS ONE Open access 4 Aug 2015 25
43 Use of drugs to treat symptoms and acute conditions during pregnancy in outpatient care in Switzerland between 2014 and 2018: analysis of Swiss healthcare claims data Eva Gerbier, Sereina M. Graber, Marlene Rauch et al. · Swiss Medical Weekly Open access 28 Nov 2021 24
44 Inappropriate use of arthroscopic meniscal surgery in degenerative knee disease Leander Muheim, Oliver Senn, Mathias Früh et al. · Acta Orthopaedica Open access 30 Jun 2017 24
45 A set of four simple performance measures reflecting adherence to guidelines predicts hospitalization: a claims-based cohort study of patients with diabetes Carola A. Huber, Michael Brändle, Roland Rapold et al. · Patient Preference and Adherence Open access Mar 2016 24
46 Appropriateness of Diagnostic Coronary Angiography as a Measure of Cardiac Ischemia Testing in Non-Emergency Patients – A Retrospective Cross-Sectional Analysis Corinne Chmiel, Oliver M. Reich, Andri Signorell et al. · PLoS ONE Open access 26 Feb 2015 24
47 Prevalence, trends, and individual patterns of long-term antidepressant medication use in the adult Swiss general population Melanie Alexandra Amrein, Michael P. Hengartner, Markus Näpflin et al. · European Journal of Clinical Pharmacology Open access 5 Sep 2023 23
48 Use of valproate in pregnancy and in women of childbearing age between 2014 and 2018 in Switzerland: a retrospective analysis of Swiss healthcare claims data Julia Spoendlin, Eva Blozik, Sereina M. Graber et al. · Swiss Medical Weekly Open access 10 Jan 2021 23
49 Increased risk of adverse events in non-cancer patients with chronic and high-dose opioid use—A health insurance claims analysis Jakob Martin Burgstaller, Ulrike Held, Andri Signorell et al. · PLoS ONE Open access 14 Sep 2020 23
50 Timing of Measles Immunization and Effective Population Vaccine Coverage Julia Anna Bielicki, Rita Achermann, Christoph T. Berger · PEDIATRICS 21 Aug 2012 23

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.